Elsevier,
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (Sixth Edition), Volume 1, 2020, Pages 283-297
This chapter addresses Goal 3 by discussing the genetic relationship between Alzheimer's disease and Down Syndrome.
The SDG Impact of COVID-19 podcast series gathers expert opinion exploring the impact of COVID-19 on the Sustainable Development Goals. In this segment, we get the view of Jo Youle, CEO of Missing People.
The SDG Impact of COVID-19 podcast series gathers expert opinion exploring the impact of COVID-19 on the Sustainable Development Goals. In this segment, we get the view of Sandra Kerr, Director of Race Equality at Business in the Community.
Neurodegenerative diseases (NDD) such as Alzheimer's (AD) and Parkinson's disease (PD) are distinct clinical entities; however, the aggregation of key neuronal proteins, presumably leading to neuronal demise appears to represent a common mechanism. It has become evident that advanced glycation end products (AGEs) trigger the accumulation of such modified proteins, which eventually contributes to the pathological aspect of NDDs. Increased levels of AGEs are found in amyloid plaques in AD brains and in both advanced and early PD (incidental Lewy body disease). The molecular mechanisms by which AGE dependent modifications may modulate the susceptibility towards NDDs, however, remain enigmatic and it is unclear whether AGEs may serve as biomarker of NDD. This study detected differential associations between NDD, sex and oxidative stress markers.
This book chapter advances SDGs 3 and 10 by explaining how individuals with diabetes who are of lower socioeconomic status are more likely to have poorer diabetes-related outcomes. Digital health advancements provide unique opportunities to reduce health inequities for this high-risk group.
Partner content
World Bank
The Atlas of Sustainable Development Goals 2020 presents interactive storytelling and data visualizations about the 17 Sustainable Development Goals.
Elsevier,
Control Theory in Biomedical Engineering Applications in Physiology and Medical Robotics 2020, Pages 205-234
This book chapter advances SDG3 Good Health and Wellbeing and SDG10 Reducing Inequalities by examining the research on wearable mechatronic devices for upper-limb amputees.
Elsevier,
Mental and Behavioral Health of Immigrants in the United States, Cultural, Environmental, and Structural Factors, 2020, Pages 157-178
This chapter addresses Goal 3 by examining the mental health of immigrants in the United States.
Elsevier,
Mental Health and Behavioral Health of Immigrants in the United States, 2020, Pages 179-200
This book chapter addresses SDG 10 and SDG 3 by discussing the ways in which contemporary South Asian Muslim American experiences are further complicated when navigating additional marginalized identities such as gender and sexual orientation, age and generational influences, disability status, class, and national origin
Elsevier,
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (Sixth Edition), Volume 1, 2020, Pages 199-207
This chapter explores a third use of neurotechnology that neither fits squarely into the category of treatment nor carries some of the moral hesitancies of pure enhancement in persons without physical or intellectual impairment. This third category, referred to as enhancement-2, is the enhancement of cognition for persons who have intellectual disabilities. This content addresses SDG 3 by giving comprehensive coverage of the neurogenetic foundation of neurological and psychiatric disease; explaining all aspects essential to the practice of neurogenetics to inform clinical diagnosis, treatment and genetic counseling.
